CD4 and neoplasm: Despite no obvious change in the total CD4+ T cells with anti-VISTA or RT treatment alone, the FoxP3/CD4+ T cell ratio significantly decreased in the group treated with anti-VISTA alone, suggesting an impact on Treg differentiation or recruitment within the tumor.